SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-050957
Filing Date
2021-08-11
Accepted
2021-08-11 17:22:51
Documents
2
Period of Report
2021-08-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 15847
2 POA DOCUMENT poa.txt EX-24.3_1003373 3765
  Complete submission text file 0001209191-21-050957.txt   21080
Mailing Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080
Business Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Issuer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O SUTRO BIOPHARMA, INC. 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080
Business Address
Vasquez Nicki (Reporting) CIK: 0001877585 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38662 | Film No.: 211164649